NCT01064063

Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Zimmer Biomet · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This evaluation is being conducted on the relative new knee system, the Vanguard Cruciate Retaining (CR) to evaluate clinical efficacy of the Vanguard CR components.

Detailed description

This clinical trial was initially designed as a multi-centre, randomized controlled study, comparing the Vanguard CR with the AGC in routine use. The study now is a single centre study. The Vanguard CR system has been specifically designed to give greater knee stability through the use of more anatomic patello-femoral kinematics.

Conditions

• Osteoarthritis
• Rheumatoid Arthritis
• Traumatic Arthritis

Interventions

Type	Name	Description
DEVICE	Vanguard CR	The Vanguard CR is a metal and polyethylene total condylar knee system. The system contains three primary components: femoral, tibial, and bearing components, and a peripheral component: the patella button.
DEVICE	AGC knee	The AGC knee is a metal and polyethylene total condylar knee system offering complete component interchangeability.

Timeline

• Start date: 2011-02-15
• Primary completion: 2013-12-15
• Completion: 2022-05-10
• First posted: 2010-02-08
• Last updated: 2025-11-26

Locations

1 site across 1 country: United Kingdom